Related Articles for PubMed (Select 18687126)

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.

Breast Cancer Res. 2008;10(4):R69. Epub 2008 Aug 7.

PMID: 18687126 [PubMed - in process]

Related Articles Free article in PMC

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.

Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ.

Clin Colorectal Cancer. 2006 Jul;6(2):125-32.

PMID: 16945168 [PubMed - indexed for MEDLINE]

[Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients]

Cai QQ, Huang HQ, Lin TX, Jiang WQ.

Ai Zheng. 2005 Jul;24(7):837-41. Chinese.

PMID: 16004811 [PubMed - indexed for MEDLINE]

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD.

Clin Cancer Res. 2002 May;8(5):1085-91.

PMID: 12006523 [PubMed - indexed for MEDLINE]

Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.

Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW, Gratama JW, Sleijfer S, Foekens JA.

Breast Cancer Res Treat. 2008 Dec 30. [Epub ahead of print]

PMID: 19115104 [PubMed - as supplied by publisher]

Molecular signature detection of circulating tumor cells using a panel of selected genes.

Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.

Cancer Lett. 2008 May 18;263(2):267-79. Epub 2008 Feb 8.

PMID: 18262345 [PubMed - indexed for MEDLINE]

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M.

Nature. 2007 Dec 20;450(7173):1235-9.

PMID: 18097410 [PubMed - indexed for MEDLINE]

Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.

Braun S, Hepp F, Kentenich CR, Janni W, Pantel K, Riethmüller G, Willgeroth F, Sommer HL.

Clin Cancer Res. 1999 Dec;5(12):3999-4004.

PMID: 10632331 [PubMed - indexed for MEDLINE]

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K.

Clin Cancer Res. 2007 Feb 1;13(3):920-8.

PMID: 17289886 [PubMed - indexed for MEDLINE]

10:

Detection of circulating tumor cells in patients with urothelial cancer.

Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF.

Ann Oncol. 2008 Oct 3. [Epub ahead of print]

PMID: 18836088 [PubMed - as supplied by publisher]

11:

Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.

Stojadinovic A, Mittendorf EA, Holmes JP, Amin A, Hueman MT, Ponniah S, Peoples GE.

Ann Surg Oncol. 2007 Dec;14(12):3359-68. Epub 2007 Sep 29.

PMID: 17906897 [PubMed - indexed for MEDLINE]

12:

Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells.

Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ.

Biotechnol Bioeng. 2009 Feb 1;102(2):521-34.

PMID: 18726961 [PubMed - in process]

13:

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.

Fehm T, Becker S, Duerr-Stoerzer S, Sotlar K, Mueller V, Wallwiener D, Lane N, Solomayer E, Uhr J.

Breast Cancer Res. 2007;9(5):R74.

PMID: 17963511 [PubMed - indexed for MEDLINE]

Recent Activity